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Abstract
Background: In areas of high-level, year-round malaria transmission, morbidity and mortality due
to malaria decrease after the first two to three years of life. This reduction may be related to the
development of cellular immunity to specific antigens expressed in the different life-cycle stages of
Plasmodium falciparum.
Methods: A cross sectional study was conducted to evaluate T cell cytokine responses to the P.
falciparum  pre-erythrocytic antigen liver-stage antigen-1 (LSA-1) and the blood-stage antigen
merozoite-surface protein-1 (MSP-1) in children under five years of age residing in a malaria
holoendemic region of western Kenya. Interferon-γ (IFN-γ) and interleukin-10 (IL-10) responses to
the LSA-1 T3 peptide (aa 1813–1835) and the MSP-1 aa20–39 peptide were tested in 48 children.
Results: The proportion of children producing IFN-γ to LSA-1 and to MSP-1 increased with age:
in the 0–12, 13–24, 25–36 and 37–48 month age groups, zero, 11.1, 36.4 and 40% of children had
IFN-γ responses to LSA-1 (p = 0.019), and 10, 10, 27.7 and 40% of children had IFN-γ responses to
MSP-1 (p = 0.07), respectively. In contrast, the proportion of children producing IL-10 to LSA-1
and MSP-1 was similar in all age groups.
Conclusion: The data suggest that development of IFN-γ responses to LSA-1 and MSP-1 requires
increased age and/or repeated exposure, whereas IL-10 responses to these antigens may occur at
any age and with limited exposure. The data also demonstrate that by the age of 4 years, children
in a malaria holoendemic area develop frequencies of IFN-γ responses to LSA-1 and MSP-1 similar
to those seen in adults in the area.
Background
In malaria holoendemic areas, where malaria is stable and
intense throughout the year, morbidity and mortality
from  Plasmodium falciparummalaria occur primarily in
children aged 6–24 months and decrease significantly
after 24 months of age [1]. Age-related protection from P.
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falciparum infection and disease in these areas is thought
to be related to acquisition of cellular and humoral
immunity to pre-erythrocytic and blood-stage P. falci-
parum antigens [2].
T lymphocyte cytokine production to P. falciparum pre-
erythrocytic and blood-stage antigens, particularly IFN-γ
and IL-10 production, appears to be important in induc-
tion and maintenance of immunity to P. falciparum in nat-
urally exposed populations [2]. The pre-erythrocytic
antigen liver-stage antigen-1 (LSA-1) is recognized by
cytotoxic T lymphocytes (CTL) in animal models and
humans naturally exposed to malaria [3,4]. In vitro studies
in areas of stable and unstable malaria transmission have
shown that LSA-1 evokes strong IFN-γ and IL-10
responses, and these responses correlate with protection
from infection [5–9]. Development of cellular immunity
to blood-stage antigen merozoite-surface protein-1 (MSP-
1) in experimental and human malaria involves mainly
CD4+ T cell IFN-γ responses [2,10–12]. In some rodent
malaria models, TH1 cells producing IFN-γ and IL-2 are
important for controlling infection in its early phases,
while TH2 cells producing IL-4 and IL-10, together with
antibodies, are important for parasite clearance in the
later phases of infection [2].
Our prior studies and those of other groups have docu-
mented that IFN-γ and IL-10 responses to LSA-1 are
present in older children (>5 years) and adults in malaria
endemic areas [5–8]. However, the frequency of these
responses in children aged 0–4 years is not well described.
An understanding of the development of IFN-γ and IL-10
responses to LSA-1 and MSP-1 in children with natural
exposure to malaria from birth to 4 years of age is impor-
tant because this age group is the target group for malaria
vaccine development.
Studies of T cell cytokine responses in young children
have been hampered by the difficulty in obtaining veni-
puncture blood samples from these children and in
obtaining adequate numbers of mononuclear cells for
testing of responses. Finger-prick blood sampling was suc-
cessfully used in this study with lower cell concentrations
to conduct a cross-sectional study of IFN-γ and IL-10
responses to LSA-1 and MSP-1 in children aged 1–48
months in a malaria holoendemic area of western Kenya.
Methods
Study population
Blood samples for cytokine testing were collected from a
total of 48 children aged 1–48 months in the location of
Kanyawegi, western Kenya, an area of intense, perennial
malaria transmission. Written informed consent was
obtained from the parents or guardians of all children
who participated in the study. Ethical approval was
obtained from the Ethical Review Committee at the Kenya
Medical Research Institute and the Human Investigations
Institutional Review Board at Case Western Reserve Uni-
versity and University Hospitals of Cleveland, Cleveland,
OH.
Blood collection and transportation
Approximately 0.5–1 ml volume of blood was collected
from each individual by finger-prick method. The finger
to be pricked was cleaned with 70% alcohol and pricked
using a sterile lancet. The first drop of blood was wiped
using dry gauze and the finger was then squeezed gently
to get 0.5–1 ml of blood in a microtainer containing the
anticoagulant EDTA (BD Microtainer™, Becton Dickson,
Franklin Lakes, USA). Blood samples were then trans-
ported to the Case Western Reserve University laboratory
at the Center for Vector Biology and Control Research,
KEMRI, Kisian, Kenya.
Microscopy
Thick and thin blood smears were stained using 5%
Giemsa solution and examined for Plasmodium species by
two microscopists. Parasite density/µl of blood was calcu-
lated by counting the number of parasites per 200 white
blood cells and multiplying by 40, assuming an average
white blood cell count of 8000/µl.
Isolation of peripheral blood mononuclear cells (PBMC) 
and cell culture
Peripheral blood mononuclear cells (PBMC) were sepa-
rated from the whole blood by Ficoll-Hypaque density
gradient centrifugation. The final pellet was suspended in
0.5 ml of RPMI 1640 medium (Gibco, Invitrogen, Paisley,
Scotland, UK) supplemented with 5% heat inactivated
human AB serum, 50 mg/ml gentamicin, 10 Mm Hepes
and 2 mM glutamine. Cells were plated in duplicate at a
final concentration of 1 × 106 cells/ml, 200 µl/well, on 96
well U-bottom microtiter plates (Microtest™, Becton Dick-
son). Cell culture supernatants were removed after 72
hours and tested for the presence of IFN-γ and IL-10.
Cytokine enzyme linked immunosorbent assay (ELISA)
Supernatant testing for IFN-γ and IL-10 was performed
using two-site ELISA. 96 well ELISA microtiter plates
(ImmulonR 4 HBX, Thermo Labsysytems, East Forge Park-
way, Franklin, USA) were coated with 50 µl/well of pri-
mary antibody and incubated at 4°C overnight. The plates
were washed twice using 1x PBS with 0.05% Tween 20
(PBS-T), blocked with 50 µl /well of 3% BSA and incu-
bated at 37°C for 1 hour. Plates were then washed twice,
and samples, standards and blanks added at 50 µl /well.
Plates were incubated at 37°C for 2 hours, washed twice
and 50 µl/well of biotinylated secondary antibody was
added. Plates were incubated at room temperature for 45
minutes, washed twice and 50 µl/well of streptavidinMalaria Journal 2003, 2 http://www.malariajournal.com/content/2/1/37
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alkaline phosphatase (Jackson ImmunoResearch, West
Grove, PA) at a 1:2000 dilution was added. Plates were
incubated for 30 minutes at room temperature and
washed six times. 50 µl /well of alkaline phosphatase sub-
strate (Sigma Diagnostics, Inc. St. Louis, MO) was added.
Optical density (O.D.) of the standards and samples were
read at 405 nm when the highest standard reached an
O.D. between 1.0 and 1.4 nm. Sample O.D. values were
compared to standards with known concentrations of
IFN-γ and IL-10 and sample concentrations extrapolated
from a standard curve. Values of baseline (unstimulated)
culture supernatants were subtracted from those of pep-
tide/mitogen-stimulated culture supernatants.
Antigens and mitogens for cytokine tests
The frequencies and levels of cytokine responses to LSA-1
and MSP-1 were tested using the previously described
MSP-1 peptide aa20 to 39, amino acid (aa) sequence
VTHESYQELVKKLEALEDAV [11] LSA-1 peptide T3 (aa
1813 to 1835), aa sequence NENLDDLDE-
GIEKSSEELSEEKI [5]. These peptides have been demon-
strated to elicit T cell cytokine responses from individuals
in malaria endemic populations [5,9,11]. Peptides were
synthesized and purified by high-performance liquid
chromatography (HPLC) to > 95% purity (Sigma Geno-
sys, St. Louis, MO) and used at a concentration of 10 µg/
ml. Phytohaemagglutinin (PHA) at 5 µg/ml and phorbol-
12-meristate-13-acetate plus Ionomycin (PMA-I) at 20 ng/
ml and 1 µg/ml, respectively, were used as positive
mitogen controls. PHA and PMA-I responses were similar.
Only PHA responses are presented in this paper.
Statistical Analysis
Only individuals with cytokine concentrations of ≥ 20 pg/
ml to PHA or PMA-I were analysed for peptide-induced
cytokine responses. Individuals with peptide-induced
cytokine concentrations of ≥ 20 pg/ml were considered
positive responders for that peptide while those with
cytokine concentrations ≤ 20 pg/ml were considered non-
responders to that peptide. Frequencies of cytokine
responses were compared across age groups (0–12, 13–
24, 25–36 and 37–48 months old) by chi-square analysis
for trend. Log-transformed cytokine levels were compared
across age groups by analysis of variance (ANOVA). For
the purpose of log transformation, all stimulated superna-
tants with no production of cytokine above media were
given a value of 1 pg/µl. Stata 7.0 (Stata Corporation,
Texas, USA) was used for all statistical analysis.
Results
Frequency and density of P. falciparum parasitaemia 
across age groups
Frequency and density of parasitemia did not differ signif-
icantly across age groups (Table 1). Presence of para-
sitemia did not correlate with IFN-γ or IL-10 responses or
levels to either LSA-1 or MSP-1 (Tables 2 and 3), and lev-
els of parasitemia did not correlate with cytokine levels to
any peptide (Spearman's rho 0.04 – 0.15, all p values
>0.1).
Frequency and levels of IFN-g and IL-10 cytokines across 
age groups
Frequencies and levels of IFN-γ and IL-10 responses to
PHA were similar across age groups (Tables 4 and 5).
However, frequencies of IFN-γ responses to LSA-1
increased significantly with age (P = 0.019) and a similar
trend was seen in frequencies of IFN-γ responses to MSP-
1 (P = 0.07) (Table 4). Geometric mean cytokine levels of
IFN-γ responses to LSA-1 and MSP-1 also increased with
age, although these increases did not achieve statistical
significance (Table 4). In contrast, frequencies and levels
of IL-10 responses were similar across age groups (Table
5). IL-10 levels were generally much lower than IFN-γ
levels.
Discussion
This study documents that IFN-γ responses to peptides
encoding T cell epitopes for the pre-erythrocytic antigen
LSA-1 and the blood-stage antigen MSP-1 are infrequent
in the first year of life but increase with age through the
age of 4 years in children in a malaria holoendemic area.
By the age of 4 years, frequency and level of IFN-γ
responses to the single LSA-1 peptide T3 exceeded those of
adults in an area of highly seasonal malaria transmission
[5], and approached those of adults in a malaria holoen-
demic area (John CC, unpublished data). Frequencies of
IFN-γ responses to the MSP-1 peptide, aa 20–39, were also
similar by the age of 4 years to those reported in other
MSP-1 peptides in adults in malaria endemic areas
[13,14]. In contrast, frequencies of IL-10 responses to LSA-
1 and MSP-1 peptides did not differ with age, and levels
and frequencies of IL-10 responses were much lower than
IFN-γ responses. These findings suggest that age and/or
Table 1: Frequencies and density of P. falciparum parasitemia, by 
age.
Age (months) No. of positives/Total 
(%)
Geo. mean density, 
parasites/µl (range)a
0–12 6/11 (54.55) 3992.73 (0–29880)
13–24 11/12 (91.67) 10466.67 (0–38360)
25–36 10/13 (76.92) 5873.85 (0–29680)
37–48 9/12 (75.00) 10083.33 (0–47120)
P NSb NSc
a Geometric mean P. falciparum density in each age group. b NS = not 
significant. P < 0.05 considered significant, as determined by χ2 test for 
homogeneity across age groups. c NS = not significant. P < 0.05 
considered significant, as determined by analysis of variance 
(ANOVA) of log-transformed P. falciparum density across age groups.Malaria Journal 2003, 2 http://www.malariajournal.com/content/2/1/37
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repeated exposure are necessary for development of IFN-γ
but not IL-10 responses to LSA-1. The low frequencies and
levels of IL-10 responses may reflect truly decreased IL-10
responses to LSA-1 and MSP-1 peptides in this popula-
tion, but they may also reflect the effects of the finger-
prick sampling method used, the relatively small number
of mononuclear cells tested (2.0 × 105 cells), and testing
for responses to single LSA-1 and MSP-1 peptides.
LSA-1 is a vaccine candidate antigen expressed exclusively
in the liver-stage of P. falciparum infection [15]. Studies in
malaria endemic areas of Africa have documented that
IFN-γ and IL-10 responses to LSA-1 correlate with protec-
tion from infection [5–9]. In addition, a recent study in
children from a malaria holoendemic area of western
Kenya documented that IFN-γ responses to a pooled
group of pre-erythrocytic antigens including LSA-1 were
associated with protection from anaemia [16]. These find-
ings suggest that IFN-γ and IL-10 responses to LSA-1 will
Table 2: Frequencies and geometric mean levels of IFN-γ responses to PHA, LSA-1 and MSP-1 peptides by presence of P. falciparum 
parasitemia
Condition PHA MSP-1 (aa 20–39) LSA-1, T3
Blood smear No. pos./Tot. (%)a Geo. mean (range)b No. pos./Tot (%) Geo. mean (range) No. pos./Tot (%) Geo. mean (range)
P. falciparum 
positive
36/36 (100) 2545.4 (164.8–6891.6) 7/32 (21.9) 145.8 (0–1245.9) 7/31 (22.6) 105.4 (0–254.3)
P. falciparum 
negative
12/12 (100) 1908 (231.1–4254.1) 2/9 (22.2) 28.4 (0–150.3) 2/8 (25.0) 39.0 (0–983.5)
P NSc NSd NS NS NS NS
a A positive response was defined as any response ≥ 20 pg/ml above that of unstimulated cell culture supernatants and had a positive or negative 
blood smear. b Geometric mean cytokine levels in pg/ml. c NS = not significant. P < 0.05 considered significant, as determined by χ2 test for trend 
across age groups. d P < 0.05 was considered significant as determined by analysis of variance of log-transformed values across age groups.
Table 3: Frequencies and geometric mean levels of IL-10 responses to PHA, LSA-1 and MSP-1 peptides by presence of P. falciparum 
parasitemia
Condition PHA MSP-1 (aa 20–39) LSA-1, T3
Blood smear No. pos./Tot. (%)a Geo. mean (range)b No. pos./Tot (%) Geo. mean (range) No. pos./Tot (%) Geo. mean (range)
P. falciparum 
positive
25/36 (69.4) 175.5 (0–847.4) 5/32 (15.6) 23.7 (0–445.9) 2/31 (6.5) 6.9 (0–125.2)
P. falciparum 
negative
11/12 (91.7) 330.1 (8.4–1247.4) 2/9 (22.2) 14.7 (0–67.7) 1/8 (12.5) 16.6 (0–125.2)
P NSc NSd NS NS NS NS
a A positive response was defined as any response ≥ 20 pg/ml above that of unstimulated cell culture supernatants and had a positive or negative 
blood smear. b Geometric mean cytokine levels in pg/ml. c NS= not significant. P < 0.05 considered significant, as determined by χ2 test for trend 
across age groups. d P < 0.05 was considered significant as determined by analysis of variance of log-transformed values across age groups.
Table 4: Frequencies and geometric mean levels of IFN-γ responses to PHA, LSA-1 and MSP-1 peptides by age.
Condition PHA MSP-1 (aa 20–39) LSA-1, T3
Age (months) No. pos./Tot. (%)a Geo. mean (range)b No. pos./Tot (%) Geo. mean (range) No. pos./Tot (%) Geo. mean (range)
0–12 11/11 (100) 2481.8 (164.9–6206.5) 1/10 (10.0) 12.2 (0–105.5) 0/9 (0.0) 0 (0–0.0)
13–24 12/12 (100) 1859.7 (95.1–3635.4) 1/10 (10.0) 124.6 (0–1245.9) 1/9 (11.1) 71.7 (0–645.2)
25–36 13/13 (100) 2875.7 (547.1–6891.6) 3/11 (27.3) 137.7 (0–1003.4) 4/11 (36.4) 68.6 (0–443.2)
37–48 12/12 (100) 2294.1 (99.8–4254.1) 4/10 (40.0) 203.7 (0–1097) 4/10 (40.0) 217.9 (0–983.5)
P NSc NSd 0.070 NS 0.019 NS
a A positive response was defined as any response ≥ 20 pg/ml above that of unstimulated cell culture supernatants. b Geometric mean cytokine levels 
in pg/ml. c NS= not significant. P < 0.05 considered significant, as determined by χ2 test for trend across age groups. d P < 0.05 was considered 
significant as determined by analysis of variance of log-transformed values across age groups.Malaria Journal 2003, 2 http://www.malariajournal.com/content/2/1/37
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be important markers of immunogenicity in LSA-1-con-
taining vaccines. IFN-γ responses to LSA-1 are thought to
mediate protection from infection by eliminating infected
hepatocytes through induction of the nitric oxide pathway
[17]. The mechanism for IL-10-associated protection from
infection is less well defined, but may involve chemoat-
traction of CD8+ T cells [18] or augmented antibody-
dependent cellular inhibition activity [6]. IFN-γ and IL-10
responses to MSP-1, a blood-stage vaccine candidate anti-
gen, have also been documented in adults in malaria
endemic areas [12–14,19], and rodent vaccination mod-
els suggest that IFN-γ responses to MSP-1 are important in
protection from infection [20,21]. Further human studies
are required to document whether IFN-γ or IL-10
responses to MSP-1 are protective in human populations.
In previous studies in a highland area of Kenya with
highly seasonal malaria transmission, it has been docu-
mented that IFN-γ responses to LSA-1 were less frequent
in children than adults but were relatively stable across
seasons, even in the absence of high-level transmission
[5]. The frequency and level of IFN-γ responses to the LSA-
1 T3 peptide tested in the present study were lower in
adults in the highland area than in children aged 3–4
years in the holoendemic area of the present study. This
suggests that repeated exposure may be the most impor-
tant factor in development of IFN-γ responses to LSA-1.
However, it is unclear whether the low frequency of IFN-γ
responses to LSA-1 in children under 2 years of age is due
to immaturity of the immune system, a need for sustained
or cumulative exposure or both factors. Children under 2
years of age are at the highest risk for severe malarial anae-
mia. In light of the protection from anaemia associated
with IFN-γ responses to pre-erythocytic antigens, as docu-
mented by Ong'echa et al [16], it will be important to
determine whether high frequencies of IFN-γ responses to
LSA-1 can be induced with LSA-1-containing vaccines in
children under 2 years of age. Interestingly, frequencies of
IFN-γ responses to LSA-1 in children aged 6 to 24 months
were similar in the present study and that of Ong'echa et
al, but PHA responses were significantly less frequent in
children in the study of Ong'echa et al (~50% vs. >90% in
the present study). The authors speculated that the low
frequency of PHA-stimulated IFN-γ responses might be
due to down-regulation of these responses by acute P. fal-
ciparum  infection. The high frequencies of PHA-stimu-
lated IFN-γ responses in the children in this study, most of
whom were infected with P. falciparum, suggest that P. fal-
ciparum infection does not down-regulate mitogen stimu-
lation of T cells, even in young children. Previous studies
[5,6] and the present study have not documented any dif-
ference in frequency or levels of IFN-γ responses to LSA-1
in individuals with or without parasitemia, demonstrat-
ing that P. falciparum infection also does not suppress
these responses in young children.
In previous studies in a highland area with highly sea-
sonal malaria, it has been documented that IL-10
responses to LSA-1 were similar in children and adults
and decreased dramatically in the absence of high trans-
mission [5]. A recent study in a malaria endemic area of
Gabon also documented similar IL-10 responses to LSA-1
in children and adults [22]. Taken together, these findings
suggest that IL-10 responses to LSA-1 are not dependent
on age or chronic, repeated exposure but may be transient
and related to recent infection, among other factors. The
IL-10 responses in this population of children were low-
level and infrequent, but these responses were from sam-
ples taken at a single time point and may have been low
for sampling or testing reasons. Given the protection from
infection seen with IL-10 responses to LSA-1 in adults and
older children in malaria endemic populations [5,6], it
will be important to assess whether IL-10 responses in
young children in this area are truly low, whether strong
IL-10 responses can be induced by vaccines with high con-
centrations of antigen or specific adjuvants, and whether
these responses are protective in this younger age group.
The similar frequencies and levels of IL-10 responses to
LSA-1 in children with and without parasitemia suggest
Table 5: Frequencies and geometric mean levels of IL-10 responses to PHA, LSA-1 and MSP-1 peptides by age.
Condition PHA MSP-1 (aa 20–39) LSA-1, T3
Age (months) No. pos./Tot. (%)a Geo. mean (range)b No. pos./Tot (%) Geo. mean (range) No. pos./Tot (%) Geo. mean (range)
0–12 7/11 (63.6) 241.4 (0–1247.0) 2/10 (20.0) 8.6 (0–48.93) 0/9 (0.0 1.3 (0–11.6)
13–24 9/12 (75.0) 155.6 (2.26–847.5) 3/10 (30.0) 19.4 (0–67.70) 1/9 (11.1) 17.5 (0–125.2)
25–36 10/13 (76.9) 195.8 (0–800.0) 0/11 (0.0) 2.7 (0–11.88) 0/11 (0.0) 1.1 (0–7.8)
37–48 10/12 (83.3) 267.7 (0.02–806.2) 2/10 (20.0) 57.9 (0–44.95) 2/10 (20.0) 16.6 (0–118.4)
P NSc NSd NS NS NS NS
a A positive response was defined as any response ≥ 20 pg/ml above that of unstimulated cell culture supernatants. b Geometric mean cytokine levels 
in pg/ml. c NS= not significant. P < 0.05 considered significant, as determined by χ2 test for trend across age groups. d P < 0.05 was considered 
significant as determined by analysis of variance of log-transformed values across age groups.Malaria Journal 2003, 2 http://www.malariajournal.com/content/2/1/37
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that active P. falciparum infection does not suppress or
increase these responses.
IFN-γ responses to the blood-stage antigen MSP-1 showed
the same age-related pattern as those to LSA-1. If the pro-
tection from malaria infection and disease associated with
IFN-γ responses to MSP-1 in rodent malaria models is
confirmed in human populations, future studies will need
to investigate whether age, repeated exposure or both are
necessary for induction of these responses.
Conclusion
The present study establishes that frequencies and levels
of IFN-γ responses to LSA-1 and MSP-1 are low in the first
2 years of life but increase to close to adult levels by the
age of 4 years, while IL-10 responses to these antigens
appear unrelated to age, in children in a malaria holoen-
demic area of Kenya. Prospective cohort studies of chil-
dren from birth to age 4 years in malaria endemic areas are
required to determine how IFN-γ and IL-10 responses to
LSA-1 and MSP-1 relate to prior infection, the longevity of
these responses, and their relation to protection from
infection and disease.
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